Skip to main navigation Skip to search Skip to main content

Alemtuzumab versus interferon beta-1a: implications for pathology and trial design

  • Henry F. McFarland

Research output: Contribution to journal › Article › peer-review

2   Link opens in a new tab Scopus citations

Fingerprint

Dive into the research topics of 'Alemtuzumab versus interferon beta-1a: implications for pathology and trial design'. Together they form a unique fingerprint.
Sort by